New drug candidate tested for obesity and hypertension safety
NCT ID NCT06148272
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 19 times
Summary
This early-phase study tests the safety of a new injectable drug, LY3971297, in healthy volunteers and people with obesity and high blood pressure. Researchers will monitor side effects and measure how the drug moves through the body. The study involves up to 225 participants across multiple parts, lasting up to 90 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CenExel ACT
RECRUITINGAnaheim, California, 92801, United States
Contact Phone: •••-•••-••••
Contact
-
Clinical Pharmacology of Miami
RECRUITINGMiami, Florida, 33172, United States
Contact Phone: •••-•••-••••
Contact
-
Clinical Research Hospital Tokyo
ACTIVE_NOT_RECRUITINGShinjuku-ku, 160-0004, Japan
-
Hakata Clinic
ACTIVE_NOT_RECRUITINGFukuoka, 812-0025, Japan
-
ICON Early Phase Services
RECRUITINGSan Antonio, Texas, 78209, United States
Contact Phone: •••-•••-••••
Contact
-
Lilly Centre for Clinical Pharmacology
RECRUITINGSingapore, 138623, Singapore
Contact Phone: •••-•••-••••
Contact
-
P-One Clinic
ACTIVE_NOT_RECRUITINGHachiōji, 192-0071, Japan
Conditions
Explore the condition pages connected to this study.